Literature DB >> 518819

Comparative studies of the metastatic potential of three transplantable rat mammary carcinomas of spontaneous origin.

N Willmott, E B Austin, R W Baldwin.   

Abstract

The metastatic potential of 3 spontaneously arising mammary carcinomas (Sp4, Sp15 and Sp22) has been examined when transplanted in the form of a viable cell suspension into the tissue of origin. Primary tumours were excised at different times after implantation and it was found that the metastatic potential of the immunogenic tumour Sp4 was directly correlated with the size of the primary tumour when excised. By contrast, the incidence of metastases from the non-immunogenic tumours Sp15 and Sp22 was similar irrespective of the size of the primary tumour on excision. The pattern of metastasis also differed between the tumours, although here there was no relation to immunogenicity. Thus, resection en bloc of large primary Sp4 or Sp15 tumours plus regional lymph nodes could be completely curative, signifying initial spread of tumours via the lymphatics and only subsequently via the blood stream. On the other hand, resection en bloc of primary Sp22 tumours plus regional lymph nodes at a similar stage of primary tumour development was never curative, signifying early spread via the blood stream. Other studies showed that the metastatic potential of mammary carcinoma Sp4 was an innate characteristic of the tumour and not related to the tissue of implantation since in addition to metastasizing from the mammary pad it metastasized when implanted either s.c. or intradermally in a region devoid of mammary tissue. Furthermore, a rat sarcoma Mc7 showed a negligible tendency to metastasize when implanted either in the mammary pad or in the s.c. tissue, where it had been induced with methylcholanthrene.

Entities:  

Mesh:

Year:  1979        PMID: 518819      PMCID: PMC2041488     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  24 in total

1.  THE RELATIONSHIP BETWEEN THE DISSEMINATION OF TUMOR CELLS AND THE DISTRIBUTION OF METASTASES.

Authors:  H S GREENE; E K HARVEY
Journal:  Cancer Res       Date:  1964-06       Impact factor: 12.701

2.  Regional differences in tumor growth: studies of the vascular system.

Authors:  R Auerbach; L W Morrissey; L Kubai; Y A Sidky
Journal:  Int J Cancer       Date:  1978-07-15       Impact factor: 7.396

3.  Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition.

Authors:  B Fisher; O Soliman; E R Fisher
Journal:  Cancer Res       Date:  1970-07       Impact factor: 12.701

4.  C. parvum immuntherapy of transplanted rat tumours.

Authors:  M V Pimm; R W Baldwin
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

Review 5.  The choice of animal tumors for experimental studies of cancer therapy.

Authors:  H B Hewitt
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

6.  Selective toxicity of anticancer drugs: Presidential Address.

Authors:  C G Zubrod
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

7.  Mechanisms and prevention of cancer dissemination: an overview.

Authors:  E V Sugarbaker; A S Ketcham
Journal:  Semin Oncol       Date:  1977-03       Impact factor: 4.929

8.  BCG treatment of transplanted rat tumours of spontaneous origin.

Authors:  M V Pimm; A J Cook; D G Hopper; A M Dickinson; R W Baldwin
Journal:  Int J Cancer       Date:  1978-10-15       Impact factor: 7.396

9.  Non-immunological enhancement of tumour transplantability in x-irradiated host animals.

Authors:  R J Jamasbi; P Nettesheim
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

10.  Further studies of the relationship between lymphatic dissemination and lymphnodal metastasis in non-immunogenic murine tumours.

Authors:  H B Hewitt; E R Blake
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

View more
  1 in total

1.  Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour.

Authors:  J C Williams; B A Gusterson; R C Coombes
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.